This Wednesday, the CDC will vote if they recommend the use of this vaccine in young people between 12 and 15 years of age.
Pfizer said on Wednesday that its vaccine against covid-19 is more effective in adolescents aged 12 to 15 than in adolescents aged 16 to 25 at a meeting where the American Science Council is reviewing data for this age range. .
The representative of the pharmaceutical company, John Perez, expressed this at a meeting of the Advisory Committee on Immunization Practices (ACIP, English).
If this independent agency of the Centers for Prevention and Control (CDC, English) recommends the use of this vaccine among young people aged 12 to 15 as the final step in its management, it will vote on Wednesday.
Perez relied on the chart to explain that in the course of the experiment, they observed that adolescents of these ages had 100% efficacy.
The doctor said that even “the immune response has surpassed that of young people between the ages of 16 and 25.”
For this reason, he emphasized that the data on “immunogenicity” (an ability of an antigen to activate the immune system) and “effectiveness” “strongly” support the use of the vaccine in adolescents between 12 and 15 years of age.
Perez also emphasized that the side effects of the vaccine in this age group are similar to those of young people aged 16 to 25, such as moderate pain during injection, fever, migraine and myalgia.
On Monday, the U.S. Food and Drug Administration (FDA) approved Pfizer’s emergency use authorization for the covid-19 vaccine used by teenagers over 12 years of age.
In this way, the regulator renewed its license to the American pharmaceutical company in December last year, when the company only authorized people over the age of 16.
After Pfizer and its partner BioNTech proved that the vaccine for this age group is 100% effective, they have applied to the U.S. authorities for emergency use of its vaccine for children between 12 and 15 years of age.
ACIP is expected to vote to recommend this vaccine for people of this age, which needs to be signed by CDC Director Rochell Walensky.
CDC’s actions will mean that these young people can be dosed at any authorized location.
Some states such as Arkansas, Delaware and Georgia have opened up the possibility of vaccination to teenagers aged 12 to 15 on Tuesday, but other states are waiting for the CDC’s advice.
Some insurances do not cover vaccines for those ages without CDC approval.